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High prevalence of the metabolic syndrome 
among newly diagnosed type 2 diabetes patients in Denmark
Few population-based data exist on the 
prevalence of the metabolic syndrome 
(MS) its components, and its association 
with subclinical inflammation and insulin 
resistance among patients newly diagnosed 
with type 2 diabetes (T2D).
89% of the newly diagnosed T2D patients 
have the MS, with 90% having elevated 
waist circumference, blood pressure and 
blood glucose, and <50% having elevated 
triglycerides and reduced HDL-cholesterol. 
In T2D patients with MS 
-    Elevated C-peptide levels are common* 
-    CRP levels are increased* 
-    the risk of previous cardiovascular disease is high* 
* as compared to non-MS patients.
We examined the MS according to the International Diabetes 
Federation (IDF) criteria from 2009 by linkage primary 
data (waist circumference, fasting blood glucose, and 
C-reactive protein (CRP)) with variables from the Danish 
Diabetes Database  for  Adults  (blood pressure  and  lipids) 
and  a  nationwide prescription database (antilipidemic, 
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Previous hospitalised with CVD 0 23.1% NRP
The number of patients in the DD2 cohort without (non) and with metabolic syndrome 
(MS) as defined by the International Diabetes Federation in 2009. *diagnosed after 1.1.2009
The number and (percent) of patients matching the criteria for the metabolic syndrome (MS) as 
defined by the International Diabetes Federation and the prevalence ration (95% confidence interval). 
Patient characteristics, numbers are median (quartile) and abbreviations are body mass index 
(BMI), bloodpressure (BP), C-reactive protein (CRP), The Danish Diabetes Database for Adults 
(DDDA), Danish Centre for Strategic Research in Type 2 Diabetes (DD2), and cardio vascular 
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